Long-Term Outcome Of Nilotinib 400 Mg Twice Daily In First-Line Treatment
Submitted by sandy craine on Tue, 27/02/2018 - 10:56am
Nilotinib is a second-generation
Anything related specifically to clinical trials.
Nilotinib is a second-generation